Literature DB >> 27140233

Alterations in glutamate cysteine ligase content in the retina of two retinitis pigmentosa animal models.

Violeta Sánchez-Vallejo1, Soledad Benlloch-Navarro1, Laura Trachsel-Moncho1, Rosa López-Pedrajas1, Inmaculada Almansa1, Francisco Javier Romero2, María Miranda3.   

Abstract

Retinitis Pigmentosa (RP) comprises a group of rare genetic retinal disorders in which one of several different mutations induces photoreceptor death. Oxidative stress and glutathione (GSH) alterations may be related to the pathogenesis of RP. GSH has been shown to be present in high concentrations in the retina. In addition, the retina has the capability to synthesize GSH. In this study, we tested whether the two subunits of glutamate cysteine ligase, the rate-limiting enzyme in GSH synthesis, and the concentrations of retinal GSH, oxidized glutathione (GSSG), cysteine (Cys) and glutamate are altered in the retina of two different RP mice models. Retinas from C3H and rd1 mice at different postnatal days (P7, P11, P15, P19, P21 and P28) and from C57BL/6 and rd10 mice at P21 were obtained. Western blot analysis was performed to determine the protein content of catalytic and modulatory subunits from glutamate cysteine ligase (GCLC and GCLM, respectively). In another set of experiments, control and rd1 mice were administered buthinine sulfoximine, a glutathione synthase inhibitor, or paraquat. GSH, GSSG, glutamate and Cys concentrations were determined, by HPLC. A decrease in retinal GCLC content was observed in C3H and rd1 mice with age, nevertheless, there was an increase in retinal GCLC in rd1 mice compared to control retinas at P19. No modifications in GCLM content with age and no difference between GCLM content in rd1 and control retinas were observed. The GSH concentration decreased in the rd1 retinas compared with control ones at P15, it increased at P19, and was again similar at P21 and P28. No changes in GSSG concentration in control retinas with age were observed; the GSSG levels in rd1 retinas were similar from P7 to P19 and then increased significantly at P21 and P28. Glutamate concentration was increased in the rd1 retinas compared to control mice from P7 to P15 and were comparable at P21 and P28. The Cys concentrations was measured in control and rd1 retinas, but no significant changes were observed between them. BSO administration decreases GSH retinal concentration in control and rd1 mice, while paraquat administration induced an increase in GSH retinal concentration in control mice and a decrease in GSH in rd1 mice retina. Retinal GCLC was significantly increased in rd10 mice at P21 as well as GSSG. Our results suggest alterations in retinal GCLC content and GSH and/or its precursors in these two RP animal models. Regulation of the enzymes related to GSH metabolism and the retinal concentration of glutamate may be a possible target to delay especially cone death in RP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cysteine; Glutamate; Glutamate cysteine ligase; Glutathione; Retina; Retinitis pigmentosa

Mesh:

Substances:

Year:  2016        PMID: 27140233     DOI: 10.1016/j.freeradbiomed.2016.04.195

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Mechanism of Cone Degeneration in Retinitis Pigmentosa.

Authors:  De-Juan Song; Xiao-Li Bao; Bin Fan; Guang-Yu Li
Journal:  Cell Mol Neurobiol       Date:  2022-07-06       Impact factor: 5.046

2.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

3.  Biochemical and Behavioral Consequences of Ethanol Intake in a Mouse Model of Metabolic Syndrome.

Authors:  Pablo Baliño; Ricard Romero-Cano; María Muriach
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

4.  Metabolic Analysis of Vitreous/Lens and Retina in Wild Type and Retinal Degeneration Mice.

Authors:  Elisa Murenu; Sarantos Kostidis; Shibojyoti Lahiri; Anna S Geserich; Axel Imhof; Martin Giera; Stylianos Michalakis
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

5.  Impact of Plasma Oxidative Stress Markers on Post-race Recovery in Ultramarathon Runners: A Sex and Age Perspective Overview.

Authors:  Carlos Guerrero; Eladio Collado-Boira; Ignacio Martinez-Navarro; Barbara Hernando; Carlos Hernando; Pablo Balino; María Muriach
Journal:  Antioxidants (Basel)       Date:  2021-02-27

6.  Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration.

Authors:  Dolores T Ramírez-Lamelas; Soledad Benlloch-Navarro; Rosa López-Pedrajas; Roberto Gimeno-Hernández; Teresa Olivar; Dolores Silvestre; María Miranda
Journal:  Front Pharmacol       Date:  2018-05-09       Impact factor: 5.810

7.  Oxidative stress and autophagy-related changes during retinal degeneration and development.

Authors:  Laura Trachsel-Moncho; Soledad Benlloch-Navarro; Ángel Fernández-Carbonell; Dolores Tania Ramírez-Lamelas; Teresa Olivar; Dolores Silvestre; Enric Poch; María Miranda
Journal:  Cell Death Dis       Date:  2018-07-24       Impact factor: 8.469

Review 8.  Nitrosative Stress in Retinal Pathologies: Review.

Authors:  Antolin Cantó; Teresa Olivar; Francisco Javier Romero; María Miranda
Journal:  Antioxidants (Basel)       Date:  2019-11-11

9.  Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases.

Authors:  María Sebastián-Morelló; Adrián M Alambiaga-Caravaca; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; María Miranda; Alicia López-Castellano
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.